AAP
SMTI icon

Arax Advisory Partners’s Sanara MedTech SMTI Stock Holding History

Arax Advisory Partners’s Portfolio SMTI Stock Details SMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$30.8K Buy
+1,307
New +$27K ﹤0.01% 3662
2025
Q4 		– Sell
-1
Closed -$31 – 4493
2025
Q3 		$31 Buy
+1
New +$30 ﹤0.01% 3558

Other funds holding SMTI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
SWM
Stonebridge Wealth Management Oak Brook, Illinois $112M AUM 23.07% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

Arax Advisory Partners's SMTI Position: Q2 2026 in Review

Arax Advisory Partners opened a new position in Sanara MedTech (SMTI) in Q2 2026: 1,307 shares worth $30.8K. The stake represents ﹤0.01% of the portfolio and ranks #3662 among its holdings. This is a return to the name: Arax Advisory Partners previously reported a position in SMTI as recently as Q3 2025.

Arax Advisory Partners first reported a position in SMTI in Q3 2025 and has held it in 2 quarters since. 75 funds tracked by Wall St. Rank hold SMTI as of Q2 2026.

  • Arax Advisory Partners held 1,307 shares of Sanara MedTech worth $30.8K as of Q2 2026.
  • Sanara MedTech was a new Arax Advisory Partners position in Q2 2026.
  • Sanara MedTech made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #3662 holding.
  • Arax Advisory Partners first reported a position in Sanara MedTech in Q3 2025 and has held it in 2 quarters since.
  • 75 funds tracked by Wall St. Rank held Sanara MedTech as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.